William Blair Issues Optimistic Outlook for BMY Earnings

Bristol-Myers Squibb (NYSE:BMY - Free Report) - Investment analysts at William Blair upped their Q2 2025 earnings per share estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday, March 11th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company w